|

NVAX Stock Price: Novavax, Inc. keeps the $143.00 mark so far

  • Novavax, Inc. (NASDAQ: NVAX) trades around Thursday’s close near $143.00.
  • Progress on its vaccine candidate remains in centre stage.

Shares of biotech Novavax, Inc. (NASDAQ: NVAX) remain mostly flat near Thursday’s close just above the $143.00 mark during the premarket activity.

Choppy week for (NASDAQ: NVAX) so far, which saw weekly gains advancing to the area past the $155.00 level at the beginning of the week, embarking into a corrective downside soon afterwards.

The US biotech stays in the centre of the debate as investors continue to monitor the progress on its COVID-19 vaccine candidate NVX-CoV2373, sharing the run up to finally develop an efficient vaccine with fellow competitors Moderna, Inc. and Pfizer, Inc.

So far this year, (NASDAQ: NVAX) is already advancing nearly 3,500%.

Novavax Stock Forecast

As of writing, (NASDAQ: NVAX) is losing 0.09% at $143.13 and faces the next support at $112.51 (monthly low Aug.11) and then $93.49 (low Jul.9). On the other hand, the next hurdle lines up at $155.75 (high Aug.17) seconded by $189.40 (high Aug.5).

Author

Pablo Piovano

Born and bred in Argentina, Pablo has been carrying on with his passion for FX markets and trading since his first college years.

More from Pablo Piovano
Share:

Editor's Picks

EUR/USD edges lower below 1.1650 as Middle East tensions fuel US Dollar strength

The EUR/USD pair trades in negative territory around 1.1635 during the early Asian session on Thursday. The US Dollar strengthens against the Euro as escalating Middle East conflict boosts safe-haven flows. Traders brace for the Eurozone Retail Sales and US weekly Initial Jobless Claims reports, which will be released later on Thursday. 

GBP/USD tests key moving averages as growth downgrade weighs

GBP/USD was nearly flat on Wednesday, edging up 0.08% to settle around 1.3370 in a quiet session. The pair has fallen sharply from its late-January high near 1.3870 and is now testing the 200-day Exponential Moving Average, with this week's one-week forex heatmap showing Pound Sterling as one of the worst performers against the US Dollar, down about 1.4% on the week.

Gold re-attempts $5,200 amid a softer USD; reduced Fed rate cut bets cap gains

Gold bounces toward $5,200 for the second consecutive day on Thursday amid a modest US Dollar weakness. Wednesday's upbeat US macro data further tempered hopes for three rate cuts by the Fed in 2026. Furthermore, escalating Middle East tensions might continue to benefit the USD's status as the global reserve currency and contribute to capping the bullion.

Ethereum jumps alongside a spike in open interest, realized price could limit upside

Ethereum has jumped above $2,100 on Wednesday, following a general recovery across the crypto market. The move was accompanied by a spike in Ethereum's open interest, which has increased to 13.43M ETH — its highest level since January 31. 

First Venezuela, now Iran: The US-China energy war escalates

At first glance, the latest escalation involving the United States with both Iran and Venezuela looks like another chapter in a long-running geopolitical story. But viewed through a broader strategic lens, something else may be unfolding: Energy.

Bittensor extends recovery despite retail demand slump

Bittensor, a leading Artificial Intelligence token, is aging up above $190 at the time of writing on Wednesday. Steady price increases characterise the broader crypto market, with Bitcoin holding above $71,000 and Ethereum above $2,000.